XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Comprehensive income        
Net income $ 1,629 $ 1,695 $ 4,514 $ 4,349
Currency translation adjustment:        
Currency translation adjustment (net of tax provision (benefit) of $(244), $71, $10 and $35) (54) (112) 748 57
Unrealized gains/(losses) on available-for-sale debt securities        
Unrealized holding losses arising during the period (net of tax (provision) benefit of $0, $0, $0 and $0) 0 0 (1) 0
Unrealized gains/(losses) on hedging instruments:        
Reclassification adjustment for losses included in net income (net of tax (provision) benefit of $0, $0, $1 and $1) 1 1 2 5
Pension and other postretirement benefit liability adjustments:        
Pension and other postretirement benefit liability adjustments arising during the period (net of tax (provision) benefit of $2, $(1), $2 and $(1)) (5) 2 (4) 2
Amortization of net loss included in net periodic pension cost (net of tax (provision) benefit of $0, $(1), $1 and $(1)) 0 0 2 (2)
Total other comprehensive income/(loss) (58) (109) 747 62
Comprehensive income 1,572 1,586 5,261 4,411
Less: comprehensive income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest 6 (26) 9 (26)
Comprehensive income attributable to Thermo Fisher Scientific Inc. $ 1,566 $ 1,612 $ 5,252 $ 4,437